Drug Discovery Leaders Warn U.S. Cuts Endanger AI Edge
As Washington trims billions from health funding, AI drug discovery leaders warn the timing could widen the gap with ...
Timing your investments in stocks vs bonds can significantly impact returns. Learn when to make your moves.
13,124 articlesAs Washington trims billions from health funding, AI drug discovery leaders warn the timing could widen the gap with ...
Apple is accelerating AI across its ecosystem. This article breaks down the two big profit engines, what it means for...
In a high-stakes clash of industry voices, Ripple's Brad Garlinghouse pushes back against Jamie Dimon's crypto cautio...
A surge of headlines about aliens and the Catholic Church is reshaping how investors think about religion, charity, a...
A stock down 2026 can still offer surprises. This guide breaks down bear, base, and bull scenarios for the next three...
A fresh health-economics study links the use of GLP-1 obesity drugs to sizable lifetime medical cost reductions for 4...
From a modest El Paso trailer to the World Cup stage, Ricardo Pepi’s journey spotlights the hidden costs of chasing a...
MercadoLibre reports 40% year-over-year growth fueled by fintech expansion and a resilient e-commerce network in Lati...
Public scandals can upend not just reputations but budgets. This article pulls financial lessons from the high-profil...
When the economy tightens, many people choose to stay in their homes longer. This guide explains why half homeowners ...
When a hotel group’s interim CEO sells a sizable stake, investors want to know if it’s a sign of trouble or routine f...
TJX has built a reputation as a reliable off-price retailer with durable demand. But for investors, does the premium...